He told an study by British Pharmacological Society and the Royal College of Physicians that testing patients for genetic variations that affect how their body will respond to common medicines must be integrated fully, fairly and swiftly into the NHS.

The report – Personalised prescribing: using pharmacogenomics to improve patient outcomes – explains how a type of testing, known as pharmacogenomic testing, should be deployed across the NHS to ensure all patients have an equal chance of being prescribed a medicine at a dose that is likely to be safe and effective for them, with minimal side effects.

There can be enormous variation from person to person in whether a medicine works, whether it causes serious side effects and what dose is needed. Scientists have established a genetic cause for such variation for over 40 medicines.

The report is published here, by British Pharmacological Society and the Royal College of Physicians.

Prof Guruprasad Aithal, NIHR Nottingham BRC deputy director and lead for the GI & Liver Disorders theme, presented evidence to the working party.

He said- ‘There are inter-individual variations in the way medicines work. Considering one’s genetic make-up assists while prescribing, increasing the benefits and reducing the adverse effect of the medications. We know of genetic variations which effect over 40 medicines. We are calling for NHS to offer genetic tests to improve safe and effective prescribing’.

His previoius public lecture on the personalising treatments through genetics is available here.

Website by Volute